Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia

NCT00554840 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT00554840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2007
Completion date
April 30, 2011
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking, schizophrenia